levodopa-carbidopa
levodopa-carbidopa is a pharmaceutical drug with 27 clinical trials. Currently 3 active trials ongoing. Historical success rate of 95.7%.
Success Metrics
Based on 22 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
13
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
95.7%
22 of 23 finished
4.3%
1 ended early
3
trials recruiting
27
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease
Montelukast in Parkinson Disease
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES
Clinical Trials (27)
Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease
Montelukast in Parkinson Disease
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES
Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa
Vision Response to Dopamine Replacement
Cognitive Remediation for Cocaine Dependence
A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease
Medications for Stopping Cocaine Dependence and Preventing Relapse
The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia
Levodopa for the Treatment of Residual Amblyopia
Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients
Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide
Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers
A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 27